SCHEMBL3087342

SCHEMBL3087342

CC(=O)C(Cc1ccccc1)C(=O)Cc1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MDM2 Q00987 1/20 0.52
ALPI P09923 1/20 0.48
PKM P14618 1/20 0.48
PTGS1 P23219 1/20 0.48
XIAP P98170 1/20 0.48
SLC7A5 Q01650 1/20 0.48
CYP1A2 P05177 1/20 0.47
CES2 O00748 1/20 0.47
CES1 P23141 1/20 0.47
AKR1B1 P15121 1/20 0.47
SLC15A1 P46059 1/20 0.46
TSHR P16473 1/20 0.44
NPC1 O15118 1/20 0.44
RAB9A P51151 1/20 0.44
MMP8 P22894 1/20 0.44
CTRB1 P17538 3/20 0.44
LTA4H P09960 1/20 0.44
ALPL P05186 1/20 0.43
POLB P06746 1/20 0.43
ALPG P10696 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3079812 0.89 MDM2 (0.50) MDM2ALPIPKMPTGS1XIAP
SCHEMBL1896075 0.86 MDM2 (0.61) MDM2ALPIPKMPTGS1XIAP
SCHEMBL28141057 0.85 MDM2 (0.52) MDM2ALPIPKMPTGS1XIAP
SCHEMBL14263733 0.85 MDM2 (0.52) MDM2ALPIPKMPTGS1XIAP
SCHEMBL9833991 0.84 ALPI (0.61) MDM2ALPIPKMPTGS1XIAP
SCHEMBL1532407 0.84 ALPI (0.61) MDM2ALPIPKMPTGS1XIAP
SCHEMBL27300438 0.84 ALPI (0.61) MDM2ALPIPKMPTGS1XIAP
SCHEMBL27762682 0.84 MDM2 (0.59) MDM2ALPIPKMPTGS1XIAP
SCHEMBL15454767 0.84 MDM2 (0.59) MDM2ALPIPKMPTGS1XIAP
SCHEMBL16344520 0.82 ALPI (0.59) MDM2ALPIPKMPTGS1XIAP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2203496-B1 PHOTOLATENT CATALYSTS BASED ON ORGANOMETALLIC COMPOUNDS BASF SE (DE) 2018-04-11 EP disclosed
US-8318830-B2 Photolatent catalysts based on organometallic compounds BASF SE (DE) 2012-11-27 US disclosed
US-20100234485-A1 PHOTOLATENT CATALYSTS BASED ON ORGANOMETALLIC COMPOUNDS BASF SE (DE) 2010-09-16 US disclosed
EP-2203496-A1 PHOTOLATENT CATALYSTS BASED ON ORGANOMETALLIC COMPOUNDS BASF SE (DE) 2010-07-07 EP disclosed
WO-2009050115-A1 PHOTOLATENT CATALYSTS BASED ON ORGANOMETALLIC COMPOUNDS BASF SE (CH) 2009-04-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100234485-A1 PHOTOLATENT CATALYSTS BASED ON ORGANOMETALLIC COMPOUNDS PUF60, TST, MPST MDM2 3500/4885ALPI 3826/4885PKM 1130/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.